Last year, Chanelle went through some major changes. The Irish company was acquired by a privateequity firm and installed new senior leaders. At the recent Animal Health, Nutrition and TechnologyInnovation Europe conference in London, S&P Global’s head of animal health Joseph Harvey spoke tothe company about its first steps under new guidance. Chanelle is currently […]
Chanelle Pharma Strengthens Leadership Team with Key Appointment Galway, February 17, 2025 – Chanelle Pharma announces the appointment of Jacob Kurdziel as Head of Corporate Development, effective immediately. Jacob will drive the strategic direction of Chanelle’s next chapter as it embarks on its corporate transformation to position itself as the preferred pharmaceutical partner within both […]
Chanelle Pharma Appoints Pat McLoughlin as General Manager 10th January’2025, GALWAY – Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health, is delighted to announce the appointment of Pat McLoughlin as General Manager. In his new role, Pat will oversee all operations across Manufacturing, Engineering, OPEX, Supply Chain, Quality Control (QC), and […]
Chanelle Pharma CEO Angelo Gatto joined a panel at the Asia Matters MedTech & Healthcare Summit in Galway, discussing global industry leadership in the MedTech and healthcare sectors. He was joined by John Nugent (IDA Ireland), Michael Gilvarry (Johnson & Johnson, Cerenovus), and Laurence May (KPMG Galway). The panel highlighted strategic innovations and opportunities shaping […]
Chanelle Pharma announces Platinum Partnership with ISPCA 09th December 2024 – Chanelle Pharma has achieved Platinum Status in the ISPCA Corporate Membership Circle. This status demonstrates our commitment to animal welfare and making a significant impact in the lives of countless animals in need. Chanelle and the ISPCA share a deep commitment to compassion, animal welfare, and community support. Through our partnership, […]
Chanelle Pharma appoints Angelo Gatto to drive growth and expansion 1st August 2024, DUBLIN – Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health, today announces the appointment of Angelo Gatto as CEO. Angelo brings 25 years of international experience in pharmaceuticals, in a career spanning animal health, human health and CDMO. He has held operational, commercial […]
Chanelle Pharma,  Ireland’s largest indigenous manufacturer of generic pharmaceuticals acquired by Exponent One of Ireland’s most successful companies, Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a leading private equity firm. Headquartered in Loughrea, Co. Galway, Chanelle Pharma is Ireland’s largest indigenous manufacturer of generic pharmaceuticals for animal and human health. […]
Chanelle Pharma
Dublin Road, Loughrea,
Co Galway, Ireland.
